Shinae Seo, Chun-Ja Kim, Se-Won Kang, Dae Jung Kim, Elizabeth A Schlenk
{"title":"Psychometric Properties of the Short-Form Revised Lifestyle Evaluation Scale for Metabolic Syndrome-Korean.","authors":"Shinae Seo, Chun-Ja Kim, Se-Won Kang, Dae Jung Kim, Elizabeth A Schlenk","doi":"10.1177/26350106251378720","DOIUrl":null,"url":null,"abstract":"<p><p>PurposeThe purpose of the study was to evaluate the validity and reliability of a short-form Revised Lifestyle Evaluation Scale for Metabolic Syndrome (RLES-MS)-Korean.MethodsA cross-sectional survey was administered to 211 people with diabetes who were taking medication for metabolic syndrome and attending an outpatient clinic at a university-affiliated hospital in Suwon, Korea. Structured questionnaires were used for the psychometric evaluation. The RLES-MS validity was examined using exploratory factor analysis, and reliability was assessed using Cronbach's alpha and McDonald's omega.ResultsThe interitem correlation analyses identified 2 low-correlation items, resulting in a 15-item scale. Factor analysis identified 4 dimensions of the RLES-MS: healthy eating and being active, monitoring and managing target goals, healthy coping, and awareness and taking medication. The 4-factor model explained 58.65% of the total variance. Item 8 (taking medication) scored the highest, and Item 2 (healthy eating) scored the lowest, followed by Item 13 (monitoring and managing the target values). Overall, Cronbach's alpha and McDonald's omega were .864 and .866, respectively. The RLES-MS showed significant associations with quality of life (<i>r</i> = .426, <i>P</i> < .001), self-efficacy (<i>r</i> = .530, <i>P</i> < .001), depressive symptoms (<i>r</i> = -.430, <i>P</i> < .001), and A1C (<i>r</i> = -.163, <i>P</i> = .018).ConclusionsThe RLES-MS showed good validity and moderate reliability, supporting its clinical use for evaluating lifestyle behaviors in Korean people with diabetes and metabolic syndrome.</p>","PeriodicalId":75187,"journal":{"name":"The science of diabetes self-management and care","volume":"51 6","pages":"578-588"},"PeriodicalIF":2.2000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The science of diabetes self-management and care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26350106251378720","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/14 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
PurposeThe purpose of the study was to evaluate the validity and reliability of a short-form Revised Lifestyle Evaluation Scale for Metabolic Syndrome (RLES-MS)-Korean.MethodsA cross-sectional survey was administered to 211 people with diabetes who were taking medication for metabolic syndrome and attending an outpatient clinic at a university-affiliated hospital in Suwon, Korea. Structured questionnaires were used for the psychometric evaluation. The RLES-MS validity was examined using exploratory factor analysis, and reliability was assessed using Cronbach's alpha and McDonald's omega.ResultsThe interitem correlation analyses identified 2 low-correlation items, resulting in a 15-item scale. Factor analysis identified 4 dimensions of the RLES-MS: healthy eating and being active, monitoring and managing target goals, healthy coping, and awareness and taking medication. The 4-factor model explained 58.65% of the total variance. Item 8 (taking medication) scored the highest, and Item 2 (healthy eating) scored the lowest, followed by Item 13 (monitoring and managing the target values). Overall, Cronbach's alpha and McDonald's omega were .864 and .866, respectively. The RLES-MS showed significant associations with quality of life (r = .426, P < .001), self-efficacy (r = .530, P < .001), depressive symptoms (r = -.430, P < .001), and A1C (r = -.163, P = .018).ConclusionsThe RLES-MS showed good validity and moderate reliability, supporting its clinical use for evaluating lifestyle behaviors in Korean people with diabetes and metabolic syndrome.